Chief Executive

Lytix Biopharma ASA

Insider activity · 24 months1 buy0 salesCumulative net flow

Dec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 1 buy · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 salesNov 26 · 0 buys · 0 sales

Total declarations

Company

▲ Purchases (1 ops.)

€8,470

▼ Sales (0 ops.)

—

Latest filing published 11 Dec 2025 for Lytix Biopharma ASA, €8,470.

Filing timeline

BuySale

Chief Executive

Chief Executive: trading record in brief

Chief Executive has a single filing on record, published on 11 December 2025: an open-market purchase of €8,470 in Lytix Biopharma ASA. One trade is not enough to describe a pattern. Source: insider filings from Oslo Børs. Past trades are no guide to future returns.

Companies and markets linked to Chief Executive

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Lytix Biopharma ASA (NO)

Declarations1 total

▲
Chief Executive
Executives11 Dec 2025(filed)Lytix Biopharma ASA
99,984 NOK10Oslo
10,000 shares@ NOK 9.9984100.0% of flowShareMERKOSLO:661716
Canonical exit: 11 Mar 2026 (T+90)

1 of 1 declaration

Chief Executive

Chief Executive: trading record in brief

Companies and markets linked to Chief Executive

Related entities